Professor Graham Ogg Receives Wellcome Discovery Award with International Team
16 April 2024
Awards General MRC TIDU MRC WIMM Research
Professor Graham Ogg, from the MRC Weatherall Institute of Molecular Medicine has been awarded funding for an international 8-year research programme from global charitable foundation Wellcome.
UK’s first registry to be set up for those at risk of type 1 diabetes
11 March 2024
Researchers from the Oxford BRC and other collaborating organisations have received funding to set up a UK registry for children and adults who are at risk of type 1 diabetes and have tested positive for diabetes autoantibodies.
World Cancer Day 2024: Highlighting cancer research at the MRC WIMM
4 February 2024
Department General MRC MHU MRC WIMM Research
This World Cancer Day, we heard from four Group Leaders at the MRC Weatherall Institute of Molecular Medicine about their work and how their groups are helping in the fight against cancer.
Race to cure type 1 diabetes gets a new boost
7 December 2023
Department General OCDEM Research
RDM group awarded £2.55 million for diabetes research.
AI tool could help thousands avoid fatal heart attacks
14 November 2023
AMIIC CVM Department General Publication Research
An Artificial Intelligence (AI) tool that can predict 10-year risk of deadly heart attacks, could transform treatment for patients who undergo CT scans to investigate chest pain, according to British Heart Foundation (BHF)-funded research presented at the American Heart Association’s Scientific Sessions in Philadelphia.
Heart attack risk decreased in new mothers by self-monitoring blood pressure at home
13 November 2023
CCRF CVM Department General Publication Research
Self-monitoring blood pressure after giving birth could help to cut new mothers’ risk of future heart disease and strokes, according to new research by Oxford researchers.
Longer-term organ abnormalities confirmed in some post-hospitalised COVID patients
25 September 2023
COVID-19 research CVM Department General OCMR Research
A study looking at the longer-term impact of COVID-19 has found that nearly a third of patients displayed abnormalities in multiple organs five months after infection, some of which have been shown through previous work to be evidence of tissue damage.
Synthetic peptides mimic anti-inflammatory properties of tick saliva chemicals
19 September 2023
CVM Department General Publication Research
Short peptides derived from anti-inflammatory ‘evasins’ released by ticks could be used to develop new treatments for anti-inflammatory disease.
New Oxford–BMS Translational Fellowships announced
13 September 2023
CVM Department General NDCLS Research
Two new Oxford–Bristol Myers Squibb Fellowships will support postdoctoral researchers and clinicians in the Radcliffe Department of Medicine.